112 Location of subsidiary atrial pacemakers following ablation of the sinus node in the goat. (16th May 2012)

• Record Type: Journal Article
• Authors: Borbas, Z; Caldwell, J; Prendergast, B; Vohra, A; Boyett, M; Dobrzynski, H; Garratt, C
• Is Part Of: Heart. Volume 98(2012)Supplement 1
• Page Start: A63
• Page End: A63
• Publication Date: 2012-05-16
• Subjects: Sinus node dysfunction -- sinus node ablation -- subsidiary atrial pacemaker; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2012-301877b.112
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Introduction: The development of sinus node dysfunction in patients may be accompanied by the emergence of subsidiary atrial pacemakers (SAPs) and/or junctional escape rhythms. It has been postulated that biological modification of SAPs may provide a potential alternative to implantation of artificial pacemakers for the treatment of sinus node disease ("biological pacemakers"). We investigated the structural and functional characteristics of SAPs in a chronic goat model. Methods: Adult female goats (n=7) underwent epicardial radiofrequency catheter ablation of the sinus node, via right thoracotomy. The endpoint for ablation was defined as a fall of heart rate by 50% accompanied by change in P wave morphology, or the emergence of a junctional rhythm. An epicardial pacing system was implanted for continuous monitoring. Single lead surface ECG, corrected sinus node/subsidiary atrial pacemaker recovery time (CSNRT, CART) and interrogation of the implanted pacemaker were performed at baseline and weekly for 4 weeks following recovery from anaesthetic. After 4 weeks epicardial mapping was performed and location of any SAPs determined. Results: Epicardial mapping preablation confirmed sinus rhythm in all goats and guided attempts at ablation. The predefined acute endpoint of ablation was achieved in six goats. In five goats the ablated surface area was no greater than a 1×2 cm, occupying the cranial half of the intercaval region near the crista terminalis, but was more extensive in two goats (including the animal with failed acute endpoint). Despite profound postablation bradycardia, no animal required pacing for more than the first 24 h post-ablation. Follow-up monitoring revealed an abnormal CART (>500 ms) in three goats, and the P wave morphology remained different from the preablation state in five goats, consistent with a non-sinus rhythm. Repeat epicardial mapping 4 weeks post-procedure revealed stable SAPs located in the caudal half of the intercaval region (low right atrium) in four goats. In two animals there was evidence of recovery of sinus node function and in a further goat the SAP was located within the interatrial septum or left atrium. Conclusion: Destruction of the sinus node in this experimental model resulted in the generation of chronic SAP activity in all animals. In the majority of cases SAPs were located in the low right atrial free wall (Abstract 112 figure 1 ) and constitute a promising stable target for electrophysiological modification in a whole animal model of sinus node disease.